Breaking News

Nitto Avecia Expands Oligonucleotide Mfg. Capacities

Adds new manufacturing facility in Milford, expands drug product capacity in Irvine

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Nitto Avecia Inc. (Avecia) is expanding its analytical development and oligonucleotide manufacturing capacities in Milford, MA, as well as drug product capacity in Irvine, CA and analytical development capabilities in Irvine and Marlboro.   Avecia, which specializes in nucleic acid manufacturing, is in advanced stages to build a new oligonucleotide drug substance manufacturing facility with additional capacity of more than 1.5mol. Earlier this year, a new 300mmol synthesizer was installed incr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters